The Unique Combination of Multi-dimensional Genomics & AI in Cancer Care
Detection
Early cancer detection by screening for tumor DNA in the blood (ctDNA).
Profiling
Next-generation sequencing (NGS) tumor profiling for precision therapies.
Monitoring
Personalized ctDNA monitoring for recurrence risk and treatment responses.
Innovation
Discovery of multi-omics targets for new drug insights and novel therapies development.
News & Updates
Get the latest news and updates of our company and medical field.
No data found
CAP-Accredited Laboratory
Within our global network of 14 NGS laboratories, Gene Solutions maintains two facilities with CAP accreditation. This specialization in next-generation sequencing (NGS) demonstrates our commitment to international laboratory benchmarks.
Our adherence to these rigorous standards supports the delivery of reliable genomic testing for patients.
Gene Solutions Laboratories CAP#9709518
